최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.41 no.2, 2020년, pp.166 - 176
고은비 (장덕한방병원) , 장권준 (장덕한방병원) , 장주영 (장덕한방병원) , 송미화 (장덕한방병원) , 신광순 (장덕한방병원)
Objectives: This study reports on the effect of Integrative Medicine Therapy (IMT) on a patient with pancreatic cancer with liver metastasis. Methods: One pancreatic cancer with liver metastasis patient was treated using IMT in conjunction with Gemcitabine/Abraxane since September 2019. The cycle wa...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
췌장암이란? | 췌장암이란 췌장에 생긴 암세포로 이루어진 종괴로, 5년 생존율이 8%에 불과한 예후가 극히 불량한 암종이다. 조직학적으로는 췌장 선암(pancreatic ductal adenocarcinoma)이 췌장암의 90%를 차지하여 선암이 통상 췌장암으로 통용되고 있다1. | |
췌장암의 5년 생존율은? | 췌장암이란 췌장에 생긴 암세포로 이루어진 종괴로, 5년 생존율이 8%에 불과한 예후가 극히 불량한 암종이다. 조직학적으로는 췌장 선암(pancreatic ductal adenocarcinoma)이 췌장암의 90%를 차지하여 선암이 통상 췌장암으로 통용되고 있다1. | |
췌장암의 치료는 어떻게 진행되는가? | 3개월로 생존기간의 연장에 큰 기대를 하기 힘든 것이 사실이다3. 완치적 치료를 위해서는 수술이 유일한 방법이나 췌장 주변의 혈관 및 림프절 침범으로 진단 당시 80%이상이 근치적 절제수술이 어려운 상태이므로 항암화학요법을 진행하게 된다4. 췌장암의 표준 현대의학적 항암화학요법 치료제는 1990년대 중반 Gemcitabine이 도입된 이후 꾸준한 연구개발이 진행되어 왔으며, 2000년대 중반 Erlotinib, 2010년경 Oxaliplatin+Irinotecan+5-fluorouracil+Leucovorin (FOLFIRINOX)요법 도입 이후 Abraxane(nab-paclitaxel) 과 Liposomal irinotecan이 개발됐다. |
Siegel RL, Miller KD, Jemal A. Cancer statistics 2018. CA Cancer J Clin 2018;68(1):7-30.
National Center Information Cancer. Goyang-si, Republic of Korea: Ministry of Health and Welfare; [cited 2019 Feb 20]. Available from: URL: https://www.cancer.go.kr
JK Park, Yoon YB, Kim YT, Ryu JK, Lee JK, Yoon WJ, et al. Survival and prognostic factors of unresectable pancreatic cancer. The Korean Journal of Medicine 2007;72(2):151-61.
Kleeff J, Korc M, Apte M, Vecchia CL, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nature Reviews 2016;2:16023.
Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine. N Engl J Med 2013;369(18):1691-703.
Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, et al. Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. J Pain Symptom Manage 2007;34(3):244-52.
Renia M, Bonettoa E, Cordio S, Passoni P, Carlo Milandri C, Cereda S, et al. Quality of life assessment in advanced pancreatic adenocarcinoma: results from a Phase III randomized trial. Pancreatology 2006;6(5):454-63.
Chang SH, Park JH, Yoo HS. A Case Report of Partial Remission of Renal Cell Carcinoma with Multiple Liver Metastases Treated with Korean Herbal Medicine in Conjunction with Targeted Anticancer Therapy Afinitor. J of Kor Traditional Oncology 2017;22(2):13-24.
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R. New response evaluation criteria in solid tumours: Revised RECIST guideline(version 1.1). Eur J Cancer 2009;45(2):228-47.
National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE) v.5.0, 2017. Available from : URL: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/
Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian journal of medical and paediatric oncology. official journal of Indian Society of Medical & Paediatric Oncology 2009;30(1):1-8.
National Comprehensive Cancer Network [internet]. Plymouth Meeting, USA : National Comprehensive Cancer Network ; [cited 2019 Jan 20]. Available from: URL : https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf
Cho YD. Supportive care for symptom relief in pancreatic cancer. Korean J Gastroenterology 2008;51(2):119-26.
Lockhart AC, Rothenberg ML, Berlin JD. Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 2005;128(6):1642-54.
Schmitz KH, Courneya KS, Matthews C, Demark Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42(7):1409-26.
Li M, Wang MM, Guo XW, Wu CY, Li DR, Zhang X, et al. Different Survival Benefits of Chinese Medicine for Pancreatic Cancer : How to Choose? Chin J Integr Med 2018;24(3):178-84.
김진목. 통합암치료 로드맵. 경기도 고양시: 서현사; 2014, p. 47, 50, 115.
Levy MH, Adolph MD, Back A, Block S, Codada SN, Dalal S, et al. Palliative care. J Natl Compr Can c Netw 2012;10(10):1284-309.
Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology Provisional Clinical Opinion : the integration of palliative care in to standard oncology care. J Clin Oncol 2012;30(8):880-7.
Herbology Editorial Committee of Nationwide College of Korean Medicine. Boncho-hak. Seoul: Younglimsa; 1991, p. 439.
Jang HJ. Molecular mechanism by which Resina Toxicodendrii induces apoptosis and suppresses chemoresistance in MCF-7/DOX cells. Graduate School of Korean Medicine, Kyunghee University 2017:16.
Park SJ, Kang HJ, Park JH, Cho CK, Yoo HS. A case report of a clinically diagnosed advanced lung cancer patient after treatment with Gunchil gyebok-Jung. J of Kor Traditional Oncology 2015;20(1):23-9.
Wong R, Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy--a case series. Acupuncture in medicine. Journal of the British Medical Acupuncture Society 2006;24(2):87-91.
Bao T, Zhang R, Badros A. Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain research and treatment 2011;2011:1-4.
Viscum album[L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival. European Journal of Cancer 2013;49(18):3788-97.
Rasi G, Silecchia G, Sinibaldi-Vallebona P. Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. International Jounal of Cancer 1994;57(5):701-5.
Mastino A, Favalli C, Grelli S. Combonation therapy with thymosin alpha 1 potentiastes the antitumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis Lung carcinoma in mice. International Journal of Cancer 1992;50(3):493-9.
Sharif-Khatibi L, Kariminia A, Khoei S, Goliaei B. Hyperthermia induces differentiation without apoptosis in permissive temperatures in human erythroleukaemia cells. Int J Hyperthermia 2007 Dec;23(8):645-55.
Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3(8):487-97.
Chang SH, Park JH, Yoo HS. A Case Report of Partial Remission of Renal Cell Carcinoma with Multiple Liver Metastases Treated with Korean Herbal Medicine in Conjunction with Targeted Anticancer Therapy Afinitor J of Kor Traditional Oncology 2017;22(2):13-24.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.